Anita Rajamani

Anita Rajamani currently serves as Associate Director and Lead of New Product Assessment at Astellas Pharma, beginning in April 2024. Prior to this role, Anita held the position of Associate Director for Gene Therapy Competitive Intelligence and Market Planning at Astellas Gene Therapies from March 2023 to October 2024. Anita's experience includes consulting at Lifescience Dynamics Limited, where insights were provided to pharmaceutical companies through extensive research from November 2019 to March 2023. Previous roles include Clinical Evaluation Specialist at Intuitive, where responsibilities involved appraising scientific publications and quality control of clinical evaluation reports, and a PhD candidate at the University of California, Davis, specializing in cardio-mechanobiology. Anita's diverse academic background includes a Bachelor of Science in Biomedical Engineering from Georgia Institute of Technology and a PhD from the University of California, Davis, with significant research contributions in cardiovascular fluid mechanics and innovative projects in medical devices.